Company: HCTI
Filing Date: 2025-02-25
Form Type: PRE 14A
Source: 0001213900-25-017146
Chunk: 0

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-25
Form: PRE 14A
Chunk 0
---
<div align='center'>UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934</div>

| Filed by the Registrant                    | ☒ |
| Filed by a Party other than the Registrant | ☐ |

Check the appropriate box:

| ☒ | Preliminary Proxy Statement                                                     |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement                                                      |
| ☐ | Definitive Additional Materials                                                 |
| ☐ | Soliciting Material under §240.14a-12                                           |

<div align='center'>HEALTHCARE TRIANGLE, INC.(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</div>

Payment of Filing Fee (Check all boxes that apply):

| ☒ | No fee required                                             |
| ☐ | Fee paid previously with preliminary materials.             |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per 
 Exchange Act Rules 14a- 6(i)(1) and 0-11                    |

<div align='center'>HEALTHCARE TRIANGLE, INC.

7901 STONERIDGE DRIVE, SUITE 

# 220
PLEASANTON, CALIFORNIA 94588

[Mail Date*], 2025</div>

Dear Healthcare Triangle Stockholder:

I am pleased to invite you to attend the 2024
Annual Meeting of Stockholders (the “Annual Meeting”) of Healthcare Triangle, Inc. (the “Company”)
to be held on Friday, March 28, 2025, at 10:00 a.m. Pacific Time. We have adopted a virtual format for our Annual Meeting to provide
a consistent and convenient experience to all stockholders regardless of location.

At this year’s virtual Annual Meeting,
our stockholders will be asked to:

(1) elect the four (4) nominees for director
who are named in the Proxy Statement;

(2) approve an amendment to the Company’s
2020 Stock Incentive Plan (“Plan”) to provide for the automatic increase in the number of shares under the Plan on
the first day of each fiscal year beginning with the 202